Amyotrophic lateral sclerosis (ALS) is a late-onset, fatal disorder in which the motor neurons
degenerate. The discovery of new drugs for treating ALS has been hampered by a lack of …

Background Alpha-synuclein (SNCA) gene expression is an important factor in the pathogenesis
of Parkinson's disease (PD). Gene multiplication can cause inherited PD, and promoter …

Background Monoclonal antibodies that target amyloid-beta (Aβ) have the potential to slow
cognitive and functional decline in persons with early Alzheimer’s disease. Gantenerumab is …

Epilepsy is a common neurological disorder, and mutations in genes encoding ion channels
or neurotransmitter receptors are frequent causes of monogenic forms of epilepsy. Here we …

Amyotrophic lateral sclerosis (ALS), a fatal disease causing progressive loss of motor neurons,
still has no effective treatment. We developed a phenotypic screen to repurpose existing …

We have biochemically purified A beta from brains of two unrelated familial Alzheimer's disease
(FAD) pedigrees with the APP717 mutation (Val→Ile) and from two sporadic Alzheimer's …

Fibrillar amyloid β protein (Aβ) deposition is increased in the brains of patients with Alzheimer's
disease (AD), and is manifested as senile plaques (SPs) and congophilic angiopathy (CA…

In this study we sought to learn about when and how amyloid beta-protein (A beta) accumulates
in the cortex of normal individuals and about the difference in the A beta accumulation …

The hallmark of Alzheimer's disease (AD) pathology is an accumulation of amyloid β (Aβ)
and phosphorylated tau, which are encoded by the amyloid precursor protein (APP) and …

To investigate the pathomechanism of amyloid β protein (Aβ) deposition in brains with
Alzheimer's disease (AD), cerebrospinal fluid (CSF) levels of Aβ species (CSF-Aβ) with different …